Follow
Jacques De Keyser
Jacques De Keyser
Professor of Neurology (emeritus)
Verified email at vub.be
Title
Cited by
Cited by
Year
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage
CS Anderson, E Heeley, Y Huang, J Wang, C Stapf, C Delcourt, R Lindley, ...
New England Journal of Medicine 368 (25), 2355-2365, 2013
16562013
Use of the Barthel index and modified Rankin scale in acute stroke trials
G Sulter, C Steen, J De Keyser
Stroke 30 (8), 1538-1541, 1999
15111999
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1238-1251, 2008
12632008
Telmisartan to prevent recurrent stroke and cardiovascular events
S Yusuf, HC Diener, RL Sacco, D Cotton, S Ôunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1225-1237, 2008
10432008
Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
J De Keyser, G Sulter, PG Luiten
Trends in neurosciences 22 (12), 535-540, 1999
5381999
Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine
L Herroelen, J De Keyser, G Ebinger
The Lancet 338 (8776), 1174-1175, 1991
4561991
Cerebral autoregulation in stroke: a review of transcranial Doppler studies
MJH Aries, JW Elting, J De Keyser, BPH Kremer, PCAJ Vroomen
Stroke 41 (11), 2697-2704, 2010
4352010
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic …
HC Diener, RL Sacco, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ...
The Lancet Neurology 7 (10), 875-884, 2008
4292008
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic …
HC Diener, RL Sacco, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ...
The Lancet Neurology 7 (10), 875-884, 2008
4292008
The European Stroke Scale.
L Hantson, W De Weerdt, J De Keyser, HC Diener, C Franke, R Palm, ...
Stroke 25 (11), 2215-2219, 1994
4271994
Interleukin-6, a mental cytokine
A Spooren, K Kolmus, G Laureys, R Clinckers, J De Keyser, G Haegeman, ...
Brain research reviews 67 (1-2), 157-183, 2011
4132011
Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials
M Uyttenboogaart, RE Stewart, PCAJ Vroomen, J De Keyser, GJ Luijckx
Stroke 36 (9), 1984-1987, 2005
3972005
Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders
J De Keyser, JP Mostert, MW Koch
Journal of the neurological sciences 267 (1-2), 3-16, 2008
3002008
Vascular aspects of multiple sclerosis
M D'haeseleer, M Cambron, L Vanopdenbosch, J De Keyser
The Lancet Neurology 10 (7), 657-666, 2011
2852011
Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot study
G Sulter, JW Elting, M Langedijk, NM Maurits, J De Keyser
Stroke 34 (1), 101-104, 2003
2652003
Tremor in multiple sclerosis
M Koch, J Mostert, D Heersema, J De Keyser
Journal of neurology 254, 133-145, 2007
2272007
Immune players in the CNS: the astrocyte
CJ Jensen, A Massie, J De Keyser
Journal of Neuroimmune Pharmacology 8, 824-839, 2013
2182013
Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations
J De Keyser, Z Gdovinová, M Uyttenboogaart, PC Vroomen, GJ Luijckx
Stroke 38 (9), 2612-2618, 2007
2182007
Imidazoline receptors, non-adrenergic idazoxan binding sites and α2-adrenoceptors in the human central nervous system
H De Vos, G Bricca, J De Keyser, JP De Backer, P Bousquet, G Vauquelin
Neuroscience 59 (3), 589-598, 1994
2121994
Lubeluzole in acute ischemic stroke: a double-blind, placebo-controlled phase II trial
HC Diener, W Hacke, M Hennerici, J Radberg, L Hantson, J De Keyser
Stroke 27 (1), 76-81, 1996
1971996
The system can't perform the operation now. Try again later.
Articles 1–20